<DOC>
	<DOCNO>NCT03094351</DOCNO>
	<brief_summary>This first randomize control study compare robot-assisted thoraco-laparoscopic esophagectomy ( RATE ) minimally invasive conventional thoraco-laparoscopic esophagectomy ( CTLE ) . The aim trial evaluate safety , risk robot-assisted esophagectomy , compare short-term operative outcome long-term oncological outcome two surgical treatment .</brief_summary>
	<brief_title>Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Minimally Invasive Conventional Thoraco-laparoscopic Esophagectomy</brief_title>
	<detailed_description>Objective : This study aim compare oncological outcome robot-assisted thoraco-laparoscopic esophagectomy minimally invasive conventional thoraco-laparoscopic esophagectomy . Study design : Randomized control parallel-group superiority trial Study population : Patients ( age &gt; = 18 &lt; = 75 year ) histologically prove surgically resectable ( cT1-4a , N0-3 , M0 ) squamous cell carcinoma intrathoracic esophagus Karnofsky score 80 . Intervention : 300 patient randomly allocate either A ) robot-assisted thoraco-laparoscopic esophagectomy ( n=150 ) B ) minimally invasive conventional thoraco-laparoscopic esophagectomy ( n=150 ) . Patients receive follow intervention : Group A. Robot-assisted thoraco-laparoscopic esophagectomy , gastric conduit formation . Group B. minimally invasive conventional thoraco-laparoscopic esophagectomy , gastric conduit formation . Main study parameters/endpoints : Primary outcome 5-year overall survival rate 5-year disease free survival rate . Secondary outcomes 3-year overall survival rate , 3-year disease free survival , ( hospital ) mortality within 30 60 day , R0 resection , operation related event , postoperative recovery , lymph node status , quality life . Follow-up : 60 month randomization .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Histologically proven squamous cell carcinoma intrathoracic esophagus . Surgical resectable ( T14a , N03 , M0 ) Age ≥ 18 ≤ 75 year Karnofsky score 80 Written inform consent Carcinoma cervical esophagus Histologically proven adenocarcinoma undifferentiated carcinoma . Prior thoracic surgery right hemithorax thorax trauma . Infectious disease systemic therapy indicate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>robot assist esophagectomy</keyword>
	<keyword>minimally invasive esophagectomy</keyword>
	<keyword>esophageal cancer</keyword>
</DOC>